Afghanistan vs Ghana: New cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Ghana
100.0%
in 2024
Afghanistan rank
1st
Ghana rank
1st
New cases tested for RR-/MDR-TB over time
- Afghanistan
- Ghana
How they compare
Afghanistan currently reports 100.0% against 100.0% in Ghana, a difference of 0.0%.
The two have swapped places 1 time across 12 shared years of data; in 2013 it was Afghanistan ahead.
Afghanistan ranks 1st and Ghana ranks 1st of 192 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 12.2% | 52.2% | 40.0% | Ghana |
| 2020s | 68.8% | 99.2% | 30.4% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Afghanistan or Ghana?
- Afghanistan, at 100.0% against 100.0% in Ghana as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Afghanistan and Ghana?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Ghana?
- 12 years are reported by both, from 2013 to 2024.
- How do Afghanistan and Ghana rank globally for new cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Ghana ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.